NW-G01, a novel cyclic hexapeptide antibiotic, produced by Streptomyces alboflavus 313: II. Structural elucidation

J Antibiot (Tokyo). 2010 May;63(5):231-5. doi: 10.1038/ja.2010.24. Epub 2010 Apr 9.

Abstract

NW-G01 is a novel cyclic hexapeptide antibiotic produced by Streptomyces alboflavus 313. Its relative structure was established by HR-ESI-MS, IR, 1D and 2D NMR techniques, the absolute structure was determined using a combination of single-crystal X-ray diffraction and Marfey's method finally. The antibiotic consists of L-valine, (3S)- and (3R)-piperazic acids, N-methyl-D-alanine and (2S,3aR,8aS)-6-chloro-3a-hydroxy-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indole-2-carboxylic acid.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / chemistry*
  • Depsipeptides / chemistry*
  • Nuclear Magnetic Resonance, Biomolecular
  • Stereoisomerism
  • Streptomyces / metabolism
  • X-Ray Diffraction

Substances

  • Anti-Bacterial Agents
  • Depsipeptides
  • NW-G01